Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription 11.05.2026 2 BMC Cancer 3 Br J Cancer 2 Cancer 1 Cancer Res 4 Eur J Gastroenterol Hepatol 1 Gastroenterology 1 Int J Cancer 2 Int J Colorectal Dis 2 J Clin Oncol 1 Lancet 1 Oncogene 1 Oncology 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. WANG LJ, Liu XY, Tan C, Wang ZW, et al
   The impact of advanced glycation end products and their receptors on the development and prognosis of colorectal cancer.
   BMC Cancer. 2026 May 6. doi: 10.1186/s12885-026-16070.
   PubMed         Abstract available
   
   
2. CAO M, Hao J, Jiang L
   SPINK4 affected M2 macrophage polarization to promote colorectal cancer malignant phenotype by PI3K/AKT pathway.
   BMC Cancer. 2026 May 7. doi: 10.1186/s12885-026-16126.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. LIN SC, Tsai YC, Wang JL, Chin HJ, et al
   Targeting NUDT21-mediated alternative polyadenylation of oncogenes ameliorates colorectal cancer malignancy and metastasis.
   Br J Cancer. 2026 May 6. doi: 10.1038/s41416-026-03451.
   PubMed         Abstract available
   
   
4. CHENG HT, Seak CJ, Cheng CY, Huang SW, et al
   The association between hospital frailty risk score and adverse inpatient outcomes in older adults with colorectal cancer.
   Br J Cancer. 2026 May 6. doi: 10.1038/s41416-026-03385.
   PubMed         Abstract available
   
   
5. AL-KHAFAJI N, Steele F, Li H, Boyden H, et al
   A comparison of overall survival from early-onset and late-onset colorectal cancer stratified by TNM stage: a systematic review.
   Br J Cancer. 2026 May 4. doi: 10.1038/s41416-026-03426.
   PubMed         Abstract available
   
   

   
   Cancer

6. LAWRENCE L
   GLP-1 RAs could reduce risk of developing colorectal cancer.
   Cancer. 2026;132:e70367.
   PubMed        
   
   
7. LAWRENCE L
   Two trials bring new advances for patients with metastatic colorectal cancer: First-line data show longer disease control in MSI-H/dMMR and higher responses in BRAF V600E.
   Cancer. 2026;132:e70368.
   PubMed        
   
   

   
   Cancer Res

8. PATEL HV, Smith AE, Chan S, Gasendo JG, et al
   The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition.
   Cancer Res. 2026;86:2273-2285.
   PubMed         Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

9. RAFI R, Yasmin N, Ghani M, Siddiqui MN, et al
   Performance of artificial intelligence software: EndoAngel, EndoAID, CAD-EYE, GI Genius, and EndoScreener in adenoma detection: an extended network meta-analysis.
   Eur J Gastroenterol Hepatol. 2026;38:706-716.
   PubMed         Abstract available
   
   
10. OIWA K, Yamamura T, Nakamura M, Maeda K, et al
    Total biopsy via endoscopic submucosal dissection is useful for the diagnosis of neoplastic lesions in patients with ulcerative colitis.
    Eur J Gastroenterol Hepatol. 2026 Feb 26. doi: 10.1097/MEG.0000000000003165.
    PubMed         Abstract available
    
    
11. BAE JK, Park JJ, Kim SU, Youn YH, et al
    Metabolic dysfunction-associated fatty liver disease is an independent risk factor for advanced colorectal adenoma or cancer.
    Eur J Gastroenterol Hepatol. 2026;38:632-638.
    PubMed         Abstract available
    
    
12. SAEED A, Yousuf S, Zain A, Kashif M, et al
    Comparison of precut endoscopic mucosal resection and endoscopic submucosal dissection in the management of colorectal polyps: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2026;38:699-705.
    PubMed         Abstract available
    
    

    
    Gastroenterology

13. SAMNANI S, Forbes N
    A Randomized Trial of Colonoscopy versus Fecal Immunochemical Testing versus Usual Care in the Detection of Colorectal Cancer.
    Gastroenterology. 2026 May 1:S0016-5085(26)06826.
    PubMed        
    
    

    
    Int J Cancer

14. WURSCHI GW, Hinz A, Schneider M, Becker JN, et al
    Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of life.
    Int J Cancer. 2026;159:198-209.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

15. LI X, Liang L, Liu ZH, Wang C, et al
    Development and external validation of an interpretable multimodal deep learning model for 5-year mortality in high-risk stage ii colorectal cancer.
    Int J Colorectal Dis. 2026 May 2. doi: 10.1007/s00384-026-05132.
    PubMed         Abstract available
    
    
16. OGAWA K, Miyamoto Y, Kawata A, Akiyama T, et al
    Perioperative and oncological outcomes of extended surgery for colorectal cancer in younger patients: a propensity score-matched study.
    Int J Colorectal Dis. 2026 May 8. doi: 10.1007/s00384-026-05140.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

17. GOGENUR I, Justesen TF, Tarpgaard LS, Bulut M, et al
    Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.
    J Clin Oncol. 2026 May 5:JCO2502274. doi: 10.1200/JCO-25-02274.
    PubMed         Abstract available
    
    
18. SHARMA MR, Powderly J, Kuboki Y, Strickler JH, et al
    Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.
    J Clin Oncol. 2026 May 1:JCO2501525. doi: 10.1200/JCO-25-01525.
    PubMed         Abstract available
    
    

    
    Lancet

19. OBAYEMI JE, Agbedinu K, Kwakye G
    Myopic medical harm: a man receives free colon cancer screening in Ghana.
    Lancet. 2026;407:1676-1677.
    PubMed        
    
    

    
    Oncogene

20. YANG MH, Sheth S, Shui B, Grabski IN, et al
    The impact of K-Ras Gly12 mutants on homeostasis and tumorigenesis in the colonic epithelium.
    Oncogene. 2026;45:1828-1839.
    PubMed         Abstract available
    
    

    
    Oncology

21. CHOU CL, Hsu HP, Li WS, Lee SW, et al
    Upregulated Claudin-18.2 Is a Poor Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy.
    Oncology. 2026;104:552-563.
    PubMed         Abstract available
    
    

    
    PLoS One

22. CHERIF A, Coaston TN, Justo M, Yalzadeh D, et al
    Association of early discharge and clinical outcomes following proctectomy for patients with rectal cancer: A NRD analysis.
    PLoS One. 2026;21:e0348125.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

23. YANG WD, Lu MR, Shen Q, Zhou PH, et al
    Lactylated NAT10 contributes to elesclomol-triggered cuproptosis via the NAT10/ac4C-DLAT-mRNA/DLAT positive feedback loop in CRC.
    Proc Natl Acad Sci U S A. 2026;123:e2501185123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum